Eli Lilly & Co. vs. Arcus Biosciences, Inc.
Eli Lilly & Co. and Arcus Biosciences, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | RCUS | |
|---|---|---|
| Market Cap | $1.14 trillion | $3.02 billion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| LLY | RCUS | |
|---|---|---|
| Dividend Yield | 0.54% | — |
LLY and RCUS split the dividend factors evenly.
Risk & Sentiment
| LLY | RCUS | |
|---|---|---|
| Short Interest | 1.29% | 0.06% |
RCUS leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, RCUS overview, RCUS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.